2026 Cost Index · original data · updated 2026-06

How much does stem cell therapy cost? (2026)

Indicative, EUR-normalised published prices for stem-cell and regenerative-therapy programmes by condition and country, shown alongside the partner-clinic range in Bulgaria (€3,000–8,000). Sources may describe different protocols and inclusions.

Direct answer: sources collected for this index publish ranges of roughly €2,000–92,000, depending on condition, protocol, provider and country. The partner clinic in Sofia publishes an indicative €3,000–8,000 range. These figures are not necessarily like-for-like.

📥 Download the data (CC BY 4.0 — free to reuse with attribution): cost by condition (CSV) · cost by country (CSV)
↪ Cite this dataset

APA: StemCellAtlas. (2026). StemCellAtlas 2026 Stem-Cell Therapy Cost Index [Data set]. https://stemcellatlas.com/en/cost-index.html

BibTeX:

@misc{stemcellatlas2026costindex,
  title  = {StemCellAtlas 2026 Stem-Cell Therapy Cost Index},
  author = {StemCellAtlas},
  year   = {2026},
  url    = {https://stemcellatlas.com/en/cost-index.html},
  note   = {Data set, CC BY 4.0}
}

Cost by condition (2026, EUR)

ConditionEU benchmark · BulgariaGlobal market rangeGlobal midpointRegistered trials
Autism Spectrum Disorder€3,000–8,000€6,440–€92,000€49,22026
Diabetes (Type 1 & 2)€3,000–8,000€6,440–€59,800€33,120240
Multiple Sclerosis€3,000–8,00092
Parkinson's Disease€3,000–8,00070
Alzheimer's Disease€3,000–8,000€18,900–€21,000€19,95041
Cerebral Palsy€3,000–8,000€6,000–€7,650€6,82541
Spinal Muscular Atrophy€3,000–8,000€15,000–€30,000€22,5005
Muscular Dystrophy€3,000–8,000€15,000–€30,000€22,50026
Rheumatoid Arthritis€3,000–8,000€9,200–€23,000€16,10044
Liver Cirrhosis€3,000–8,000€19,300–€24,000€21,65089
Anemia€3,000–8,000€5,000–€25,000€15,000538
Arterial Hypertension€3,000–8,000€5,000–€25,000€15,00035
Erectile Dysfunction€3,000–8,000€20,100–€23,400€21,75035
Male Infertility€3,000–8,000€7,000–€25,000€16,00015
Primary Immunodeficiency€3,000–8,000€19,000–€24,000€21,50092
Aesthetic & Anti-Ageing€3,000–8,000€4,600–€13,800€9,20010
Intellectual Disability€3,000–8,0002
Knee Osteoarthritis€3,000–8,000€2,760–€9,200€5,980166
Back Pain & Disc Degeneration€3,000–8,000€4,600–€13,800€9,20035
Peripheral Neuropathy€3,000–8,000€2,300–€4,600€3,45050
Stroke Recovery€3,000–8,000€18,400–€27,600€23,000110
COPD & Lung Disease€3,000–8,000€16,560–€23,000€19,78034
Crohn's & IBD€3,000–8,000€20,000–€27,500€23,75089
Lupus (SLE)€3,000–8,000€9,200–€23,000€16,10047
Chronic Kidney Disease€3,000–8,000€15,000–€30,000€22,50088
Hair Loss & Restoration€3,000–8,000€1,840–€5,520€3,68017
Long COVID€3,000–8,000€2,700–€23,000€12,85011
Spinal Cord Injury€3,000–8,000€23,000–€36,800€29,90070
Heart Failure & Cardiac Repair€3,000–8,000€18,400–€46,000€32,200125
ALS (Motor Neurone Disease)€3,000–8,000€19,100–€24,000€21,55065
Psoriasis€3,000–8,000€9,200–€23,000€16,10011
Osteoporosis & Bone Health€3,000–8,000€4,600–€7,350€5,97514
Tendon & Sports Injuries€3,000–8,000€3,680–€9,200€6,44023
Chronic Wounds & Ulcers€3,000–8,000€5,000–€15,000€10,00060
Macular Degeneration & Vision€3,000–8,000€9,200–€27,600€18,40044
Fibromyalgia & Chronic Fatigue€3,000–8,000€5,000–€25,000€15,0001
Hip Osteoarthritis€3,000–8,000€4,600–€9,200€6,90012
Scleroderma (Systemic Sclerosis)€3,000–8,000€20,000–€27,500€23,75044
Premature Ovarian Insufficiency€3,000–8,000€6,440–€23,000€14,72035
Menopause & Hormonal Health€3,000–8,000€6,440–€23,000€14,72010
Complex Regional Pain Syndrome€3,000–8,000€5,000–€25,000€15,0002
Ulcerative Colitis€3,000–8,000€20,000–€27,500€23,75015

Cost by country (2026, EUR)

CountryTypical treatment rangeSource
Method & sources

Figures are indicative, compiled from published clinic and medical-tourism pricing and EUR-normalised (1 USD ≈ 0.92 EUR, 2026-06). Condition figures reflect global market ranges; the EU benchmark is the partner-clinic published range. Use the full-cost calculator for your personal all-in total. Licensed CC BY 4.0 — cite as "StemCellAtlas 2026 Cost Index".

Sources & further reading

Interactive cost-by-country charts → · Treatment options by condition →

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information